AI assistant
Fluent, Inc. — Director's Dealing 2015
Aug 12, 2015
34456_dirs_2015-08-12_2cdcde1e-bd5b-457a-b915-f4c73adb3125.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDI, Inc. (IDI)
CIK: 0001460329
Period of Report: 2015-08-11
Reporting Person: FROST PHILLIP MD ET AL (10% Owner)
Reporting Person: Frost Gamma Investments Trust (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-08-11 | Common Stock | P | 5000 | $7.6593 | Acquired | 4849588 | Indirect |
Footnotes
F1: The shares were purchased in multiple transactions at prices ranging from $7.515 to $7.91, with a weighted average price per share of $7.6593.
F2: This Form 4 does not include up to 900,108 shares of common stock of the Issuer that may be issued to Frost Gamma Investments Trust to the extent certain revenue targets are achieved as set forth in that certain Merger Agreement and Plan of Reorganization dated December 14, 2014 to which the Issuer is a party.
F3: These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.